Spok Achieves Top Client Satisfaction Scores for Seventh Consecutive Year
Spok Achieves Top Client Satisfaction Scores for Seventh Consecutive Year
In the 2024 Black Book Market Research LLC survey, Spok ranked No. 1 by healthcare industry clients
Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a leader in healthcare communications, earned top honors for the seventh consecutive year in a survey of healthcare industry clients by Black Book Market Research on top-rated clinical communications platforms.
“We are honored by the unwavering trust our healthcare clients have in Spok as their go-to partner for clinical communications,” said Vincent D. Kelly, chief executive officer of Spok Holdings, Inc. “The achievement of securing the top position for seven consecutive years underscores our commitment to delivering cutting-edge communication technology that transforms hospital and health system communication, which ultimately enhances patient care and safety.”
Spok received the highest honors for customer satisfaction in 12 of the 18 copyrighted key performance indicators Black Book Research measures, including strategic alignment of client goals, innovation, breadth of offerings, account management support and customer care, and best-of-breed technology and process improvement.
Black Book Market Research LLC measures customer satisfaction across eighteen copyrighted key performance indicators: Strategic Alignment of Client Goals including VBC, RCM & Telehealth; Innovation and Optimization; Training and Education; Client Relationships and Cultural Fit; Trust, Accountability, Transparency, Ethics; Breadth of Offerings, Client Types, Delivery Excellence; Deployment and Implementation; Customization; Integration and Interfaces; Scalability, Client Adaptability, Flexible Pricing; Compensation and Employee Performance; Reliability; Brand Image and Marketing Communications; Marginal Value Adds and Modules; Financial Stability & Managerial Viability; Data Security, Patient Privacy, and Backup Services; Account Management Support and Customer Care; and Best of Breed Technology and Process Improvement.
Black Book's independent user surveys aim to inform healthcare technology buyers about vendors exceeding expectations, as rated by current and former customers across all organizational user levels. For methodology, auditing, resources, comprehensive research, and ranking data, see http://blackbookmarketresearch.com.
About Spok
Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK), headquartered in Alexandria, Virginia, is proud to be a global leader in healthcare communications. We deliver clinical information to care teams when and where it matters most to improve patient outcomes. Top hospitals rely on the Spok Care Connect® platform to enhance workflows for clinicians and support administrative compliance. Our customers send over 70 million messages each month through their Spok® solutions. Spok enables smarter, faster clinical communication. For more information, visit spok.com.
Spok is a trademark of Spok Holdings, Inc. Spok Care Connect and Spok Mobile are trademarks of Spok, Inc.
Jill Smith
+1 (952) 451-1892
jill.smith@spok.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240402676864/en/
-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom